Symbicort 160 mcg 4.5 mcg Turbuhaler - 120 Doses

Symbicort 160Iu Turbuhaler 120 Doses

Description:

Symbicort 160Iu Turbuhaler 120 Doses is a prescription maintenance inhalation medicine used for long-term control of asthma and chronic obstructive pulmonary disease (COPD). It combines an inhaled corticosteroid (ICS) and a long-acting beta2-agonist (LABA) in a dry powder inhaler (Turbuhaler) to help reduce airway inflammation and keep the airways open, improving breathing and reducing the frequency of asthma attacks and COPD exacerbations. This product is classified as a medicine and should be used only under medical supervision as part of a comprehensive asthma or COPD management plan.

Indications:

• Long-term maintenance treatment of asthma in adults and adolescents when a combination (inhaled corticosteroid + long-acting bronchodilator) is appropriate.
• Management of moderate to severe persistent asthma with symptoms such as wheezing, chest tightness, shortness of breath, and night-time awakenings.
• Maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, to reduce exacerbations and improve lung function (when prescribed by a doctor).
• Helps decrease the frequency and severity of asthma attacks and COPD flare-ups when used regularly as directed.
• Not indicated for immediate relief of acute bronchospasm or sudden asthma attacks; a separate fast-acting reliever inhaler (such as salbutamol) is required for emergencies.

Active Ingredients / Key Components:

• Budesonide – inhaled corticosteroid (exact dose per inhalation in this 160Iu presentation is not clearly specified in the available data; typical Symbicort strengths include 160 mcg budesonide, but the precise concentration for this specific product is not confirmed and therefore cannot be stated with certainty).
• Formoterol fumarate dihydrate – long-acting beta2-adrenergic agonist (LABA) bronchodilator (exact dose per inhalation in this 160Iu presentation is not clearly specified in the available data; typical Symbicort strengths include 4.5 mcg or 9 mcg formoterol, but the precise concentration for this specific product is not confirmed and therefore cannot be stated with certainty).
• Other excipients: The full list of inactive ingredients (such as lactose monohydrate and other carrier substances) is not available in the provided information. Please refer to the official package leaflet for a complete excipient list.

Dosage & Administration / How to Use:

• Use exactly as prescribed by your physician. Do not change the dose or frequency without medical advice.
• Typical adult and adolescent dosing for asthma or COPD often involves 1–2 inhalations once or twice daily, but the exact regimen for Symbicort 160Iu Turbuhaler depends on your condition, severity, and your doctor’s instructions.
• For maintenance therapy: Inhale the prescribed number of doses every day, even when you feel well, to maintain control of symptoms.
• Not for acute attacks: Do not use this inhaler to treat sudden shortness of breath or wheezing. Always keep a fast-acting reliever inhaler (e.g. salbutamol) available for emergencies as directed by your doctor.
• How to use the Turbuhaler:
  • Step 1: Unscrew and remove the protective cap.
  • Step 2: Hold the Turbuhaler upright with the red grip at the bottom.
  • Step 3: Twist the red grip fully in one direction, then back again until you hear a click. This loads one dose of medicine.
  • Step 4: Breathe out gently away from the mouthpiece (do not blow into the device).
  • Step 5: Place the mouthpiece between your teeth, close your lips around it, and inhale strongly and deeply through your mouth.
  • Step 6: Remove the inhaler from your mouth and hold your breath for about 5–10 seconds or as long as comfortable, then breathe out slowly.
  • Step 7: If a second inhalation is prescribed, repeat the steps above.
  • Step 8: Replace the cap tightly after use.
• After each use, rinse your mouth with water and spit it out to help reduce the risk of oral thrush and hoarseness.
• Do not shake the Turbuhaler; it is a dry powder inhaler and does not require shaking.
• If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed one.
• Use in children should only be under strict medical supervision and according to pediatric dosing guidelines determined by a specialist.

Clinical Benefits:

• Provides dual action by reducing airway inflammation (budesonide) and relaxing bronchial smooth muscle (formoterol) for improved breathing control.
• Helps prevent and reduce the frequency of asthma attacks and COPD exacerbations when used regularly as maintenance therapy.
• Improves lung function and respiratory capacity, supporting better exercise tolerance and daily activity performance.
• Reduces symptoms such as wheezing, chest tightness, coughing, and night-time shortness of breath.
• Convenient dry powder Turbuhaler device delivering a fixed combination of two medicines in one inhaler, supporting better adherence to treatment.
• May reduce the need for frequent use of short-acting reliever inhalers when asthma or COPD is well controlled.

Warnings & Contraindications:

• Use only under the supervision of a healthcare professional and strictly according to the prescribed dose.
• Not for relief of acute asthma attacks or sudden episodes of breathlessness. Always carry and use a fast-acting reliever inhaler for emergencies as directed by your doctor.
• Contraindicated in patients with known hypersensitivity or allergy to budesonide, formoterol, or any of the excipients.
• Use with caution in patients with cardiovascular diseases (such as ischemic heart disease, arrhythmias, hypertension), hyperthyroidism, diabetes mellitus, severe liver disease, or seizure disorders.
• Long-term use of high-dose inhaled corticosteroids may be associated with systemic effects such as adrenal suppression, decreased bone mineral density, cataract, or glaucoma; regular medical monitoring is recommended.
• May increase the risk of oral fungal infections (thrush); rinsing the mouth after inhalation is important.
• LABA-containing medicines should not be used as monotherapy in asthma; they must always be combined with an inhaled corticosteroid, as in this product.
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Your doctor will weigh the benefits and potential risks.
• Inform your doctor about all other medicines you are taking, especially other inhalers, beta-blockers, diuretics, MAO inhibitors, tricyclic antidepressants, or systemic corticosteroids.
• Do not stop using Symbicort suddenly without medical advice, as this may worsen asthma or COPD control.
• Consult your doctor before use if you have tuberculosis (active or latent), chronic infections, or significant immune suppression.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision and prescription.
• Keep out of reach of children.

Side Effects:

• Common side effects may include throat irritation, hoarseness, cough, dry mouth, and oral fungal infection (thrush).
• Other possible effects: headache, palpitations, tremor, nervousness, mild chest discomfort, or muscle cramps due to the bronchodilator component.
• Less common but more serious side effects may include worsening breathing, paradoxical bronchospasm, severe allergic reactions (rash, swelling, difficulty breathing), or significant changes in blood pressure or heart rate.
• Long-term use of inhaled corticosteroids at high doses may rarely affect adrenal function, bone density, eye health (cataract, glaucoma), or cause growth retardation in children; regular monitoring is recommended.
• If you experience sudden worsening of breathing, chest pain, severe palpitations, signs of allergy, or no improvement in symptoms, seek immediate medical attention.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and moisture. Do not expose to excessive heat. Keep the Turbuhaler tightly closed when not in use. Do not store in the bathroom. Keep out of reach of children.

Specifications:

• Product type: Prescription maintenance inhalation medicine for asthma and COPD.
• Form: Dry powder inhaler (Turbuhaler).
• Dose count: 120 doses per Turbuhaler.
• Active ingredients: Budesonide (inhaled corticosteroid) + Formoterol (long-acting beta2-agonist); exact microgram concentrations for this 160Iu presentation are not specified in the available data.
• Intended users: Adults and adolescents as prescribed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.